Physician profile
Peter A Khamvongsa
NPI 1356385918
$66,753.30
in general payments reported to CMS, 2019-2025
36 companies · $9,203 in 2025
The $9,203 reported for 2025 was more than what 98% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,949 · 2020: $1,570 · 2021: $5,169 · 2022: $6,929 · 2023: $20K · 2024: $22K · 2025: $9,203.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $31K · Consulting Fee: $13K · Food and Beverage: $4,227 · Travel and Lodging: $3,608 · Education: $32.62.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $30,642.50 |
| Consulting Fee | $12,627.48 |
| Food and Beverage | $4,226.92 |
| Travel and Lodging | $3,607.69 |
| Education | $32.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $35,531.33 | 2022-2025 | Veozah |
| Meditrina | $9,821.06 | 2020-2025 | |
| Medical Device Business Services, INC. | $5,760.76 | 2023-2024 | Stratafix, Harmonic |
| Abbvie INC. | $5,077.47 | 2019-2023 | |
| Scynexis, INC. | $1,384.00 | 2022 | |
| Gynesonics, INC. | $1,259.67 | 2020-2022 | |
| Intuitive Surgical, INC. | $1,225.16 | 2019-2025 | Da Vinci Surgical System |
| Dysis Medical, INC. | $1,200.00 | 2019-2020 | |
| Acessa Health INC. | $1,176.50 | 2022 | |
| Hologic Sales and Service, LLC | $1,097.62 | 2021-2025 | Acessa Provu System, Myosure Tissue Removal Device, Novasure |
| Coloplast Corp | $588.00 | 2021-2025 | Altis |
| Caldera Medical, INC | $540.73 | 2021-2023 | Desara |
| Biogen, INC. | $321.91 | 2024-2025 | Zurzuvae |
| Coopersurgical, INC. | $282.49 | 2021-2024 | Wallach Cryosurgical Equipment, Paragard T 380a, Advincula Delineator Uterine Manipulator |
| Conmed Corporation | $253.04 | 2021-2025 | Airseal |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Momentis Surgical INC. | $212.00 | 2022 | |
| Medtronic, INC. | $154.51 | 2022 | |
| Pfizer INC. | $118.38 | 2022-2025 | |
| Therapeuticsmd, INC. | $113.39 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $105.08 | 2023 | Myfembree |
| Myovant Sciences INC. | $104.47 | 2021-2022 | |
| Axonics, INC. | $74.84 | 2023 | Axonics |
| Bayer Healthcare Pharmaceuticals INC. | $53.95 | 2019-2023 | |
| Millicent US INC | $43.64 | 2020-2025 | Intrarosa, Femlyv |
| Mycovia Pharmaceuticals, INC. | $36.43 | 2022-2023 | Vivjoa |
| Avion Pharmaceuticals | $28.88 | 2021-2023 | Balcoltra |
| Mimedx Group, INC. | $27.33 | 2025 | |
| Evofem Biosciences, INC. | $24.49 | 2021 | |
| Femselect INC. | $22.47 | 2025 | Enplace |
| Mayne Pharma Commercial LLC | $21.57 | 2021 | |
| Agile Therapeutics, INC. | $19.00 | 2021 | |
| Exact Sciences Corporation | $16.35 | 2023 | Cologuard Collection Kit |
| Lupin INC. | $14.95 | 2019 | |
| Mylan Pharmaceuticals INC. | $14.61 | 2020 | |
| Urovant Sciences INC | $14.46 | 2021 | |
| Duchesnay USA Incorporated | $12.76 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Khamvongsa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.